A comparative study of the in vitro permeation characteristic of sulphadiazine across synthetic membranes and eschar tissue

International Wound Journal

Volumn 5, Issue 5, 2008, Pages 633-638

  Zadeh, Behzad Sharif Makhmal ^a   Moghimi, Hamidreza ^a   Santos, Paulo ^b   Hadgraft, Jonathan ^b   Lane, Majella E ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Burn wounds; Carbosil; Eschar; Silicone; Silver sulphadiazine

Indexed keywords

SILICONE; SULFADIAZINE; SULFADIAZINE SILVER;

AQUEOUS SOLUTION; ARTICLE; BURN; COMPARATIVE STUDY; DIFFUSION COEFFICIENT; HUMAN; IN VITRO STUDY; PRIORITY JOURNAL;

ADMINISTRATION, CUTANEOUS; ADULT; ANTI-INFECTIVE AGENTS, LOCAL; AREA UNDER CURVE; BURNS; DEBRIDEMENT; DIFFUSION; DRUG EVALUATION, PRECLINICAL; HUMANS; LINEAR MODELS; MALE; PERMEABILITY; SILICONES; SILVER SULFADIAZINE; SKIN ABSORPTION; SKIN CARE; SOLUBILITY; SOLUTIONS; TISSUE DISTRIBUTION; WOUND HEALING; WOUND INFECTION;

EID: 58149385712     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/j.1742-481X.2008.00539.x     Document Type: Article

References (19)

1. Garner JP, Heppell PSJ. Cerium nitrate in the management of burns. Burns 2005 31 : 539 47.
2. White J, Thomas J, Maass DL, Horton JW. Cardiac effects of burn injury complicated by aspiration pneumonia-induced sepsis. Am J Physiol Heart Circ Physiol 2003 285 : H47 58.
3. Church D, Elsayed S, Reid O, Winston B, Lindsay R. Burn wound infections. Clin Microbiol Rev 2006 19 : 403 434.
4. Williams WG. Pathophysiology of burn wounds. In : Herndon DN, editor. Total burn care. London : Saunders, 2002 : 514 22.
5. Fitzwater J, Purdue GF, Hunt JL, O'Keefe GE. The risk factors and time course of sepsis and organ dysfunction after burn trauma. J Trauma 2003 54 : 959 66.
6. Boyce ST, Warden GD. Principles and practices for treatment of cutaneous wounds with cultured skin substitutes. Am J Surg 2002 183 : 445 56.
7. Ross DA, Phipps AJ, Clarke JA. The use of cerium nitrate-silver sulphadiazine as a topical burns dressing. Br J Plast Surg 1993 46 : 582 4.
8. Naoum JJ, Roehl KR, Wolf SE, Herndon DN. The use of homograft compared to topical antimicrobial therapy in the treatment of second-degree burns of more than 40% total body surface area. Burns 2004 30 : 548 51.
9. Iervolino M, Raghavan SL, Hadgraft J. Membrane penetration enhancement of ibuprofen using supersaturation. Int J Pharm 2000 198 : 229 38.
10. Pellet MA, Watkinson AC, Hadgraft J, Brain KR. An ATR-FTIR investigation of the interaction between vehicles and a synthetic membrane. Proc Int Symp Control Rel Bioact Mater 1994 21 : 439 40.
11. Nastruzzi C, Esposito E, Pastesini C, Gambari R, Menegatti E. Comparative study on the release kinetics of methyl-nicotinate from topic formulations. Int J Pharm 1993 90 : 43 50.
12. Feldstein MM, Raigorodskii IM, Iordanskii AL, Hadgraft J. Modeling of percutaneous drug transport in vitro using skin-imitating Carbosil membrane. J Control Release 1998 52 : 25 40.
13. de Gracia CG. An open study comparing topical silver sulfadiazine and topical silver sulfadiazine-cerium nitrate in the treatment of moderate and severe burns. Burns 2001 27 : 67 74.
14. Atiyeh BS, Hayek SN, Gunn SW. New technologies for burn wound closure and healing-review of the literature. Burns 2005 31 : 944 56.
15. Kasting GB, Filloon TG, Francis WR, Meredith MP. Improving the sensitivity of in vitro skin penetration experiments. Pharm Res 1994 11 : 1747 54.
16. Okamoto H, Komatsu H, Hashida M, Sezaki H. Effects of [beta]-cyclodextrin and di-O-methyl-[beta]-cyclodextrin on the percutaneous absorption of butylparaben, indomethacin and sulfanilic acid. Int J Pharm 1986 30 : 35 45.
17. Tsipouras N, Rix CJ, Brady PH. Passage of silver ions through membrane-mimetic materials, and its relevance to treatment of burn wounds with silver sulfadiazine cream. Clin Chem 1997 43 : 290 301.
18. Walker M, Hulme TA, Rippon MG, Walmsley RS, Gunnigle S, Lewin M, Winsey S. In vitro model(s) for the percutaneous delivery of active tissue repair agents. J Pharm Sci 1997 86 : 1379 84.
19. Yamazaki M, Kakeya N, Morishita T, Kamada A, Aoki M. Biological activity of drugs. XI. Relation of structure to the bacteriostatic activity of sulfonamides. (2). Chem Pharm Bull 1970 18 : 708 14.